Sign inTry free

Finckenstein Friedrich Graf

Chief Medical Officer of Iovance Biotherapeutics

As of Nov 10, 2026: Finckenstein Friedrich Graf (CMO, IOVA) reported no shares bought or sold themselves in the last 12 months (Form 4). IOVA's Quality Score is 5. Scores as of 10:56 PM ET, 15 minutes behind.

No shares they bought or sold themselves in the last 12 months. Their newest Form 4, for Jun 5: stock unit conversion (7,813 IOVA shares).

Bought: $0, 12 monthsSold: $0, 12 monthsLast filed: Jun 5, stock unit conversion

From SEC Form 4s · Insiders have 2 business days to file a trade

Every trade Finckenstein Friedrich Graf reported

None in the last 12 months, as filed.

Every Form 4 Finckenstein Friedrich Graf filed, as filed, on EDGAR

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See IOVA's 14 chart checksSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Finckenstein Friedrich Graf's companies

Where Finckenstein Friedrich Graf files, with the stock's Quality Score
StockTradesQuality Score
Iovance Biotherapeutics (IOVA) logoIovance Biotherapeutics (IOVA) logoIOVAIovance BiotherapeuticsCMO05

Alerts for Finckenstein Friedrich Graf

An email for each Form 4 Finckenstein Friedrich Graf files, with the stock's Quality Score.
Set an alert

A free account. No card.

Use this page

Kept by Andrew Gomes, Breakaway's founder, from the SEC's Form 4 filings. Updated Jun 5, 2026.

Their filings on the SEC's site

Free to reuse with a link to this page.

How to cite

Breakaway, Finckenstein Friedrich Graf: Chief Medical Officer at IOVA, Jun 5, 2026, getbreakaway.com/insiders/finckenstein-friedrich-graf

Journalists: email support@getbreakaway.com for the data behind this page.

Others who file at Iovance Biotherapeutics

Insider trades by person

Every insider trade, with its stock's score.

Real-time prices, every Form 4 on every stock with its Quality Score, sorting, filters, and optional alerts when the people you follow file.

See the last 30 days of insider trades

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9, 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

May we record how this site is used and measure our ads? Privacy policy

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.